In this week's issue of "The Tan Sheet", Perrigo reveals its equivalent of Reckitt Benckiser's Mucinex is out for the count -- or at least for much of the private labeler's fiscal 2011 -- after an appeals court ruled against Perrigo in a patent infringement suit.
Food safety reform is showing signs of a late-round comeback in the Senate, which has been sitting on the legislation since late 2009. Dietary supplement industry stakeholders are bracing for a battle royal once food safety reaches conference committee, given the House bill does not exempt supplement manufacturers from certain provisions.
Also on our Aug. 16 fight card, FDA reminds industry it can deploy a variety of weapons through its current recall authority. Meanwhile, GlaxoSmithKline promotes both fighters in an online ad campaign pitting BC Powder and Goody's pain relievers against each other and letting consumers vote for their favorite. The fight may not be fixed, but the winner will most definitely be GSK.
(For more blow-by-blow news and analysis of the OTC and supplement industries, tune in to "The Tan Sheet." Get your first issue free by clicking here.)
TOP STORIES
FDA Warns In Recall Guidance Agency Has Arsenal Of Enforcement Options
FDA warns that even though it cannot mandate a drug recall, "it can take more authoritative legal actions" against firms selling defective health products.
Food Safety Legislation Shows Signs Of Life In Senate
Food safety enforcement legislation looks likely to pass in the Senate after Congress returns from its August recess.
Perrigo's Generic Mucinex Becomes A Long Shot To Launch In Fiscal 2011
Perrigo further delays plans for a generic version of Reckitt Benckiser's Mucinex, saying the product it once touted as a 2010 highlight may not emerge even during the firm's fiscal 2011.
- In BC And Goody's Voting, Glaxo Cannot Lose
DIETARY SUPPLEMENTS
- Martek Plans 2011 Supplement Launches Through Amerifit Subsidiary
- Supplement Firms Must Calculate Risk From Claims To Survive, Attorneys Say
- Sales & Earnings In Brief
ON THE HILL
- Safe Cosmetics Act Lays Groundwork For Future Action
NEW PRODUCTS
- New Products In Brief
FDA
- Citizen Petitions Are No Place To Request Enforcement Action, FDA Says
IN BRIEF
- Warning letter cites hormone creams
- Walgreens, Rite Aid offer online pharmacist chat
- States subpoena J&J information
- FTC pursues firms advertising "free" product trials
- Sidley Austin recruits Senger
- Glaxo finds execs selling resveratrol supplements
- EU regulators dismiss soy heart health claim
- FDA finds drugs in EZVille supplements
- Canada NHP license regs in effect
- Dan Schiff (d.schiff@elsevier.com)
